|
Volumn 71, Issue 1, 2014, Pages 68-73
|
Clinical worsening in reversible cerebral vasoconstriction syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL BLOCKING AGENT;
CORTICOSTEROID;
MAGNESIUM;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BRAIN ISCHEMIA;
BRAIN PERFUSION;
CLINICAL EFFECTIVENESS;
CLINICAL FEATURE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG EFFICACY;
FEMALE;
GENERAL CONDITION DETERIORATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NEUROIMAGING;
OBSERVATIONAL STUDY;
OUTCOME ASSESSMENT;
PATIENT ASSESSMENT;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME;
SCORING SYSTEM;
SUBARACHNOID HEMORRHAGE;
THUNDERCLAP HEADACHE;
TRAUMATIC BRAIN INJURY;
CASE REPORT;
CLINICAL TRIAL;
COMPLICATION;
DISEASE COURSE;
HEADACHE DISORDERS, PRIMARY;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
SYNDROME;
TIME;
VASOSPASM, INTRACRANIAL;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
DISEASE PROGRESSION;
FEMALE;
HEADACHE DISORDERS, PRIMARY;
HUMANS;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
RECURRENCE;
RETROSPECTIVE STUDIES;
SYNDROME;
TIME FACTORS;
VASOSPASM, INTRACRANIAL;
YOUNG ADULT;
|
EID: 84892393209
PISSN: 21686149
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaneurol.2013.4639 Document Type: Article |
Times cited : (89)
|
References (13)
|